Status:
TERMINATED
Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
Lead Sponsor:
Stanford University
Conditions:
Myeloproliferative Disorders
Myeloproliferative Disorders (MPD)
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utiliz...
Eligibility Criteria
Inclusion
- Any patient who carries a diagnosis of a myeloproliferative disorder (MPD).
Exclusion
- Any patient who is not willing to give consent.
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01144780
Start Date
September 1 2009
End Date
June 1 2012
Last Update
April 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305